Deep Dive: How AI is now essential in biopharma

Big Pharma is incorporating AI technology to enhance drug development, inspiring new biotechs to innovate in drug discovery.

Big Pharma is incorporating AI technology to enhance drug development, a shift that has also inspired a new generation of biotechs to innovate in the field of drug discovery.

These upstart biotechs are leveraging AI to push the boundaries of what is possible in drug development, often with more agility and creativity than their larger counterparts.

The integration of AI in biopharma is a significant development, as it has the potential to accelerate the discovery and development of new treatments and therapies.